Prospective Validation of the "Rhino Conjunctivitis Allergy-Control-Score(c)" (RC-ACS(C))

Clinical and Translational Allergy - United Kingdom
doi 10.1186/2045-7022-2-17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Epicutaneous Immunotherapy in Rhino-Conjunctivitis and Food Allergies: A Review of the Literature

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

Vitamin C and the Risk of Developing Inflammatory Polyarthritis: Prospective Nested Case-Control Study

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2004English

Appear on the Cover of C&en at the Acs Spring National Meeting

Chemical and Engineering News
Chemical Engineering
2010English

Surgical Pleth Index: Prospective Validation of the Score to Predict Moderate-To-Severe Postoperative Pain

British Journal of Anaesthesia
AnesthesiologyPain Medicine
2019English

Gad C 1 Efficiency in the Diagnosis of Fish Allergy in Children

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2013English

Prospective Validation of a Clinical Score for Males Presenting With an Acute Scrotum

Academic Emergency Medicine
MedicineEmergency Medicine
2017English

Prospective Validation of the Objective Prognostic Score for Advanced Cancer Patients in Diverse Palliative Settings

Journal of Pain and Symptom Management
NeurologyAnesthesiologyPain MedicineNursing
2016English

Validation of the Use of POSSUM Score in Enteric Perforation Peritonitis - Results of a Prospective Study

Pan African Medical Journal
Medicine
2011English

Prediction of Early Ventilator Associated Pneumonia Using Clinical Pulmonary Infection Score and C-Reactive Protein- A Prospective Observational Study

Journal of Medical Science And clinical Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy